1 |
ESR2
| 7件: Endocrine resistance Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, GnRH secretion, Pathways in cancer, Chemical carcinogenesis - receptor activation, Breast cancer | D00105
D00105
|
Estradiol
| 7件: 13 13, 46, 49, 65, 76, 226, 299 |
2 |
ESR2
| 7件: Endocrine resistance Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, GnRH secretion, Pathways in cancer, Chemical carcinogenesis - receptor activation, Breast cancer | D00185
D00185
|
Estriol
| 2件: 13 13, 227 |
3 |
ESR2
| 7件: Endocrine resistance Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, GnRH secretion, Pathways in cancer, Chemical carcinogenesis - receptor activation, Breast cancer | D00575
D00575
|
Mestranol
| 2件: 46 46, 49 |
4 |
ESR2
| 7件: Endocrine resistance Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, GnRH secretion, Pathways in cancer, Chemical carcinogenesis - receptor activation, Breast cancer | D00962
D00962
|
Clomifene
| 1件: 74 74 |
5 |
ESR2
| 7件: Endocrine resistance Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, GnRH secretion, Pathways in cancer, Chemical carcinogenesis - receptor activation, Breast cancer | D00966
D00966
|
Tamoxifen
| 4件: 2 2, 86, 113, 227 |
6 |
ESR2
| 7件: Endocrine resistance Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, GnRH secretion, Pathways in cancer, Chemical carcinogenesis - receptor activation, Breast cancer | D01161
D01161
|
Fulvestrant
| 2件: 49 49, 86 |
7 |
ESR2
| 7件: Endocrine resistance Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, GnRH secretion, Pathways in cancer, Chemical carcinogenesis - receptor activation, Breast cancer | D01413
D01413
|
Estradiol
| 7件: 13 13, 46, 49, 65, 76, 226, 299 |
8 |
ESR2
| 7件: Endocrine resistance Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, GnRH secretion, Pathways in cancer, Chemical carcinogenesis - receptor activation, Breast cancer | D01413
D01413
|
Estradiol valerate
| 1件: 65 65 |
9 |
ESR2
| 7件: Endocrine resistance Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, GnRH secretion, Pathways in cancer, Chemical carcinogenesis - receptor activation, Breast cancer | D01617
D01617
|
Estradiol
| 7件: 13 13, 46, 49, 65, 76, 226, 299 |
10 |
ESR2
| 7件: Endocrine resistance Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, GnRH secretion, Pathways in cancer, Chemical carcinogenesis - receptor activation, Breast cancer | D01953
D01953
|
Estradiol
| 7件: 13 13, 46, 49, 65, 76, 226, 299 |
11 |
ESR2
| 7件: Endocrine resistance Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, GnRH secretion, Pathways in cancer, Chemical carcinogenesis - receptor activation, Breast cancer | D01986
D01986
|
Estriol
| 2件: 13 13, 227 |
12 |
ESR2
| 7件: Endocrine resistance Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, GnRH secretion, Pathways in cancer, Chemical carcinogenesis - receptor activation, Breast cancer | D02217
D02217
|
Raloxifene
| 1件: 46 46 |
13 |
ESR2
| 7件: Endocrine resistance Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, GnRH secretion, Pathways in cancer, Chemical carcinogenesis - receptor activation, Breast cancer | D04061
D04061
|
Estradiol
| 7件: 13 13, 46, 49, 65, 76, 226, 299 |
14 |
ESR2
| 7件: Endocrine resistance Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, GnRH secretion, Pathways in cancer, Chemical carcinogenesis - receptor activation, Breast cancer | D04063
D04063
|
Estradiol
| 7件: 13 13, 46, 49, 65, 76, 226, 299 |
15 |
ESR2
| 7件: Endocrine resistance Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, GnRH secretion, Pathways in cancer, Chemical carcinogenesis - receptor activation, Breast cancer | D04064
D04064
|
Estradiol
| 7件: 13 13, 46, 49, 65, 76, 226, 299 |
16 |
ESR2
| 7件: Endocrine resistance Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, GnRH secretion, Pathways in cancer, Chemical carcinogenesis - receptor activation, Breast cancer | D04065
D04065
|
Estradiol
| 7件: 13 13, 46, 49, 65, 76, 226, 299 |
17 |
ESR2
| 7件: Endocrine resistance Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, GnRH secretion, Pathways in cancer, Chemical carcinogenesis - receptor activation, Breast cancer | D07726
D07726
|
Clomifene
| 1件: 74 74 |
18 |
ESR2
| 7件: Endocrine resistance Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, GnRH secretion, Pathways in cancer, Chemical carcinogenesis - receptor activation, Breast cancer | D08409
D08409
|
Prasterone
| 6件: 49 49, 53, 83, 86, 96, 113 |
19 |
ESR2
| 7件: Endocrine resistance Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, GnRH secretion, Pathways in cancer, Chemical carcinogenesis - receptor activation, Breast cancer | D08465
D08465
|
Raloxifene
| 1件: 46 46 |
20 |
ESR2
| 7件: Endocrine resistance Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, GnRH secretion, Pathways in cancer, Chemical carcinogenesis - receptor activation, Breast cancer | D08559
D08559
|
Tamoxifen
| 4件: 2 2, 86, 113, 227 |
21 |
ESR2
| 7件: Endocrine resistance Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, GnRH secretion, Pathways in cancer, Chemical carcinogenesis - receptor activation, Breast cancer | D11513
D11513
|
Estetrol
| 1件: 53 53 |
22 |
ESR2
| 7件: Endocrine resistance Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, GnRH secretion, Pathways in cancer, Chemical carcinogenesis - receptor activation, Breast cancer | D11514
D11514
|
Estetrol
| 1件: 53 53 |